Peripheral Vascular

Yale has a long tradition of being at the forefront of interventional innovation, currently we are heavily involved in different clinical trials including iliac and SFA stent intervention, drug – eluting angioplasty balloons, carotid stenting, and renal denervation therapy. Our advanced vascular medicine and endovascular interventional training pathway provides comprehensive training for physicians to pursue an independently funded academic career in vascular medicine. The overall intent of the program is to train the next generation of leaders in the emerging field of vascular medicine.

The Vascular Medicine Outcomes, or VAMOS program, serves communities by improving vascular health outcomes. Co-founded by Carlos Mena, MD and Kim Smolderen, MD, VAMOS is among the few dedicated research programs in the U.S. focused on improving patient outcomes for peripheral vascular disease in particular.

The VAMOS program serves communities by improving vascular health outcomes. Partnerships with various stakeholders, a multi-disciplinary and patient-centered approach are key components of the VAMOS program.